These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37726067)

  • 1. ALK-Rearranged Epithelioid Mesenchymal Neoplasm: Expanding the Spectrum of Tyrosine Kinase-Altered Mesenchymal Tumors.
    Gestrich CK; Davis JL; Biederman L; John I; Alaggio R; Giovannoni I; Arnold MA; Shenoy A; Tchakarov A; Al-Ibraheemi A
    Mod Pathol; 2023 Dec; 36(12):100334. PubMed ID: 37726067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALK-rearranged Mesenchymal Neoplasms: A Report of 9 cases Further Expanding the Clinicopathologic Spectrum of Emerging Kinase Fusion Positive Group of Tumors.
    Dermawan JK; DiNapoli SE; Mullaney KA; Sukhadia P; Agaram NP; Dickson BC; Antonescu CR
    Genes Chromosomes Cancer; 2023 Feb; 62(2):75-84. PubMed ID: 36125853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK.
    Mariño-Enríquez A; Wang WL; Roy A; Lopez-Terrada D; Lazar AJ; Fletcher CD; Coffin CM; Hornick JL
    Am J Surg Pathol; 2011 Jan; 35(1):135-44. PubMed ID: 21164297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superficial ALK-rearranged myxoid spindle cell neoplasm: a cutaneous soft tissue tumor with distinctive morphology and immunophenotypic profile.
    Dermawan JK; Azzato EM; Goldblum JR; Rubin BP; Billings SD; Ko JS
    Mod Pathol; 2021 Sep; 34(9):1710-1718. PubMed ID: 34088997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelioid inflammatory myofibroblastic sarcoma: a clinicopathological, immunohistochemical and molecular cytogenetic analysis of five additional cases and review of the literature.
    Yu L; Liu J; Lao IW; Luo Z; Wang J
    Diagn Pathol; 2016 Jul; 11(1):67. PubMed ID: 27460384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histologic characterization of paediatric mesenchymal neoplasms treated with kinase-targeted therapy.
    Baranov E; Winsnes K; O'Brien M; Voss SD; Church AJ; Janeway KA; DuBois SG; Davis JL; Al-Ibraheemi A
    Histopathology; 2022 Aug; 81(2):215-227. PubMed ID: 35543076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous VCL::ALK fusion ovoid-spindle cell neoplasm.
    Helm M; Chang A; Fanburg-Smith JC; Zaenglein AL; Helm K
    J Cutan Pathol; 2023 May; 50(5):405-409. PubMed ID: 36843055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ALK oncoproteins in atypical inflammatory myofibroblastic tumours: novel RRBP1-ALK fusions in epithelioid inflammatory myofibroblastic sarcoma.
    Lee JC; Li CF; Huang HY; Zhu MJ; Mariño-Enríquez A; Lee CT; Ou WB; Hornick JL; Fletcher JA
    J Pathol; 2017 Feb; 241(3):316-323. PubMed ID: 27874193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelioid inflammatory myofibroblastic sarcoma with VCL-ALK fusion of central nervous system: case report and brief review of the literature.
    Chopra S; Maloney N; Wang WL
    Brain Tumor Pathol; 2022 Jan; 39(1):35-42. PubMed ID: 34743247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uterine inflammatory myofibroblastic tumor harboring novel NUDCD3-ROS1 and NRP2-ALK fusions: clinicopathologic features of 4 cases and literature review.
    Zhang L; Luan L; Shen L; Xue R; Huang J; Su J; Huang Y; Xu Y; Wang X; Shao Y; Ji Y; Xu C; Hou Y
    Virchows Arch; 2023 Mar; 482(3):567-580. PubMed ID: 36624188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abdominal inflammatory myofibroblastic tumour: Clinicopathological and molecular analysis of 20 cases, highlighting potential therapeutic targets.
    Vernemmen AIP; Samarska IV; Speel EM; Riedl RG; Goudkade D; de Bruïne AP; Wouda S; van Marion AM; Verlinden IV; van Lijnschoten I; Friederich P; Winnepenninckx VJL; Zur Hausen A; Sciot RME; van den Hout MFCM
    Histopathology; 2024 Apr; 84(5):794-809. PubMed ID: 38155480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytopathologic features of epithelioid inflammatory myofibroblastic sarcoma with correlation of histopathology, immunohistochemistry, and molecular cytogenetic analysis.
    Lee JC; Wu JM; Liau JY; Huang HY; Lo CY; Jan IS; Hornick JL; Qian X
    Cancer Cytopathol; 2015 Aug; 123(8):495-504. PubMed ID: 26139079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALK-rearranged Mesenchymal Neoplasms With Prominent Foamy/Pseudolipogenic Cell Morphology: Expanding the Phenotypic Spectrum of ALK Fusion Neoplasms and Report of Novel Fusion Partners.
    Agaimy A; Stoehr R; Fisher C; Chrisinger JSA; Demicco EG; Tögel L; Michal M; Michal M
    Am J Surg Pathol; 2024 Jul; ():. PubMed ID: 38979776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral and maxillofacial sclerosing epithelioid fibrosarcoma: report of five cases.
    Folk GS; Williams SB; Foss RB; Fanburg-Smith JC
    Head Neck Pathol; 2007 Sep; 1(1):13-20. PubMed ID: 20614275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory myofibroblastic tumor of the uterus: a clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumors.
    Rabban JT; Zaloudek CJ; Shekitka KM; Tavassoli FA
    Am J Surg Pathol; 2005 Oct; 29(10):1348-55. PubMed ID: 16160478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spindle cell variant of epithelioid cell histiocytoma (spindle cell histiocytoma) with ALK gene fusions: Cases series and review of the literature.
    Kazlouskaya V; Ho J; Jedrych J; Karunamurthy A
    J Cutan Pathol; 2021 Jul; 48(7):837-841. PubMed ID: 33217002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelioid fibrous histiocytoma: molecular characterization of ALK fusion partners in 23 cases.
    Dickson BC; Swanson D; Charames GS; Fletcher CD; Hornick JL
    Mod Pathol; 2018 May; 31(5):753-762. PubMed ID: 29327718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Durable Clinical Response to ALK Tyrosine Kinase Inhibitors in Epithelioid Inflammatory Myofibroblastic Sarcoma Harboring
    Wang Z; Geng Y; Yuan LY; Wang MM; Ye CY; Sun L; Dai WP; Zang YS
    Front Oncol; 2022; 12():761558. PubMed ID: 35237506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uterine Inflammatory Myofibroblastic Neoplasms With Aggressive Behavior, Including an Epithelioid Inflammatory Myofibroblastic Sarcoma: A Clinicopathologic Study of 9 Cases.
    Collins K; Ramalingam P; Euscher ED; Reques Llanos A; García A; Malpica A
    Am J Surg Pathol; 2022 Jan; 46(1):105-117. PubMed ID: 34138797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGFR1 gene fusions in a subset of pediatric mesenchymal tumors: Expanding the genetic spectrum of tumors sharing histologic overlap with infantile fibrosarcoma and "NTRK-rearranged" spindle cell neoplasms.
    Warmke LM; Al-Ibraheemi A; Wang L; Parham D; Rudzinski ER; Stohr BA; Miles C; Habeeb O; Davis JL
    Genes Chromosomes Cancer; 2023 Nov; 62(11):641-647. PubMed ID: 37265193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.